We are live on ! Find out more
OVID icon

Ovid Therapeutics
OVID

81 hedge funds and large institutions have $153M invested in Ovid Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,700% more call options, than puts

Call options by funds: $28K | Put options by funds: $1K

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

22% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 23

5% more funds holding

Funds holding: 77 → 81 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.41% less ownership

Funds ownership: 73.28% → 70.87% (-2.4%)

8% less capital invested

Capital invested by funds: $167M → $153M (-$13.9M)

Holders
81
Holders Change
+4
Holders Change %
+5.19%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
28
Reduced
23
Closed
8
Calls
$28K
Puts
$1K
Net Calls
+$27K
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$3.29M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$746K
3
Millennium Management
Millennium Management
New York
+$488K
4
Citadel Advisors
Citadel Advisors
Florida
+$456K
5
UOC
UBS O'Connor
Illinois
+$385K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$10M
2
Morgan Stanley
Morgan Stanley
New York
-$562K
3
BlackRock
BlackRock
New York
-$417K
4
VPC
Vestal Point Capital
New York
-$275K
5
BCM
Bridgeway Capital Management
Texas
-$273K
Name Holding Trade Value Shares
Change 		Change in
Stake
IGWM
76
ICA Group Wealth Management
Colorado
$168 – – –
Qube Research & Technologies (QRT)
77
Qube Research & Technologies (QRT)
United Kingdom
$165 +$181 +54 New
FFA
78
Frazier Financial Advisors
Ohio
$31 +$33 +10 New
AWM
79
Avior Wealth Management
Nebraska
$30 +$33 +10 New
SIS
80
Sound Income Strategies
Florida
$18 +$20 +6 New
VPC
81
Vestal Point Capital
New York
– -$275K -85,429 Closed
Mirae Asset Global Investments
82
Mirae Asset Global Investments
South Korea
– -$109K -33,996 Closed
VF
83
Virtu Financial
New York
– -$78K -24,264 Closed
Susquehanna International Group
84
Susquehanna International Group
Pennsylvania
– -$71.5K -22,220 Closed
State Board of Administration of Florida Retirement System
85
State Board of Administration of Florida Retirement System
Florida
– -$55.5K -17,230 Closed
NDSI
86
Newman Dignan & Sheerar Inc
Rhode Island
– -$53.2K -16,522 Closed
CG
87
Cutler Group
California
– -$6K -2,100 Closed
PNC Financial Services Group
88
PNC Financial Services Group
Pennsylvania
– -$32 -10 Closed
Carson Wealth (CWM LLC)
89
Carson Wealth (CWM LLC)
Nebraska
– +$17 +5 New
1 2 3
4

OVID Hedge Fund Activity: Q1 2024 in Review

81 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Ovid Therapeutics (OVID) for Q1 2024, worth a combined $153M — down 8.4% from $167M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new OVID positions and 8 closed out — a net gain of 4 holders — while 28 added to existing stakes and 23 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $3.29M. The largest seller was BVF Inc, cutting an estimated $10M.

  • 81 institutional investors held Ovid Therapeutics (OVID) as of Q1 2024, up from 77 in Q4 2023.
  • Funds reported $153M of Ovid Therapeutics stock for Q1 2024, down 8.4% quarter-over-quarter.
  • 12 funds opened new Ovid Therapeutics positions in Q1 2024 and 8 closed out, a net change of +4 holders.
  • The largest Ovid Therapeutics buyer in Q1 2024 was Prosight Management, an estimated $3.29M added.
  • The largest Ovid Therapeutics seller in Q1 2024 was BVF Inc, an estimated $10M sold.

Based on aggregated 13F filings for Q1 2024.